RELATED EXPERIENCE

Brown Rudnick represented transnational pharmaceutical company Lupin on its strategic licensing agreement with InspiRX Inc.  The agreement grants Lupin exclusive rights to promote, distribute and market the InspiraChamber® Anti-Static Valved Holding Chamber in the United States.  Rob Funsten, Co-Chair of Brown Rudnick's Global Life Sciences Group, was the lead attorney on the transaction.

To learn more about this deal, please read the following press release:

Lupin Launches InspiraChamber® Anti-Static Valved Holding Chamber (VHC) in the US, Expands US Brands Portfolio